Comments
Loading...
TELA Bio Analyst Ratings and Price Targets | NASDAQ:TELA | Benzinga
TELA Bio Inc has a consensus price target of $8.5 based on the ratings of 6 analysts. The high is $15 issued by Canaccord Genuity on March 28, 2023. The low is $2 issued by Piper Sandler on March 21, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, Citizens Capital Markets, and Piper Sandler on March 21, 2025, respectively. With an average price target of $5.33 between Canaccord Genuity, Citizens Capital Markets, and Piper Sandler, there's an implied 439.81% upside for TELA Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Citizens Capital Markets
Piper Sandler
JMP Securities
Lake Street
1calculated from analyst ratings
Analyst Ratings for TELA Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | Buy Now | 608.5% | Canaccord Genuity | Caitlin Cronin38% | $12 → $7 | Maintains | Buy | Get Alert |
| 03/21/2025 | Buy Now | 608.5% | Citizens Capital Markets | David Turkaly53% | $12 → $7 | Maintains | Market Outperform | Get Alert |
| 03/21/2025 | Buy Now | 102.43% | Piper Sandler | Matt O'Brien49% | $5 → $2 | Downgrade | Overweight → Neutral | Get Alert |
| 11/08/2024 | Buy Now | 406.07% | Piper Sandler | Matt O'Brien49% | $8 → $5 | Maintains | Overweight | Get Alert |
| 10/04/2024 | Buy Now | 1114.57% | Canaccord Genuity | Caitlin Cronin38% | $12 → $12 | Maintains | Buy | Get Alert |
| 08/13/2024 | Buy Now | 1114.57% | JMP Securities | David Turkaly53% | $15 → $12 | Maintains | Market Outperform | Get Alert |
| 08/13/2024 | Buy Now | 709.72% | Lake Street | Frank Takkinen34% | $14 → $8 | Maintains | Buy | Get Alert |
| 08/13/2024 | Buy Now | 709.72% | Piper Sandler | Matt O'Brien49% | $10 → $8 | Maintains | Overweight | Get Alert |
| 08/13/2024 | Buy Now | 1114.57% | Canaccord Genuity | Caitlin Cronin38% | $14 → $12 | Maintains | Buy | Get Alert |
| 07/25/2024 | Buy Now | 1317% | Canaccord Genuity | Caitlin Cronin38% | $14 → $14 | Maintains | Buy | Get Alert |
| 05/10/2024 | Buy Now | 912.15% | Piper Sandler | Matt O'Brien49% | $12 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | Buy Now | 1418.22% | JMP Securities | David Turkaly53% | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/22/2024 | Buy Now | 1114.57% | Piper Sandler | Matt O'Brien49% | $15 → $12 | Maintains | Overweight | Get Alert |
| 12/27/2023 | Buy Now | 1317% | Lake Street | Frank Takkinen34% | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
| 11/10/2023 | Buy Now | 1418.22% | JMP Securities | David Turkaly53% | $20 → $15 | Maintains | Market Outperform | Get Alert |
| 03/28/2023 | Buy Now | 1418.22% | Canaccord Genuity | Kyle Rose67% | → $15 | Reiterates | → Buy | Get Alert |
| 03/22/2023 | Buy Now | 1924.29% | JMP Securities | David Turkaly53% | → $20 | Reiterates | → Market Outperform | Get Alert |
| 11/10/2022 | Buy Now | 1924.29% | JMP Securities | David Turkaly53% | $22 → $20 | Maintains | Market Outperform | Get Alert |
| 11/10/2022 | Buy Now | 1418.22% | Piper Sandler | Matt O'Brien49% | $20 → $15 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for TELA Bio (TELA) stock?
The latest price target for TELA Bio (NASDAQ:TELA) was reported by Canaccord Genuity on March 21, 2025. The analyst firm set a price target for $7.00 expecting TELA to rise to within 12 months (a possible 608.50% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TELA Bio (TELA)?
The latest analyst rating for TELA Bio (NASDAQ:TELA) was provided by Canaccord Genuity, and TELA Bio maintained their buy rating.
When was the last upgrade for TELA Bio (TELA)?
There is no last upgrade for TELA Bio
When was the last downgrade for TELA Bio (TELA)?
The last downgrade for TELA Bio Inc happened on March 21, 2025 when Piper Sandler changed their price target from $5 to $2 for TELA Bio Inc.
When is the next analyst rating going to be posted or updated for TELA Bio (TELA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TELA Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TELA Bio was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
Is the Analyst Rating TELA Bio (TELA) correct?
While ratings are subjective and will change, the latest TELA Bio (TELA) rating was a maintained with a price target of $12.00 to $7.00. The current price TELA Bio (TELA) is trading at is $0.99, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.